{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958550",
  "id": "02958550",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250616",
  "time": "0849",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06kry6q0bbr2wh.pdf",
  "summary": "- **Litigation Update**:  \n  - **Hearing date set for 9 September 2025** to determine validity of Cosette's termination of the Scheme Implementation Deed (SID).  \n  - Cosette seeks declaration of valid termination, break fee payment (~$1.2M), or damages, plus alleges misleading conduct by Mayne Pharma.  \n  - Mayne Pharma disputes all claims and will defend the proceedings.  \n\n- **Scheme Meeting**:  \n  - Proceeding as scheduled on **18 June 2025**; directors unanimously recommend voting in favor of the scheme (subject to no superior proposal).  \n\n- **Key Risk**: Outcome of litigation could materially impact merger execution and capital structure.  \n\n*No financial or operational metrics disclosed.*",
  "usage": {
    "prompt_tokens": 1450,
    "completion_tokens": 154,
    "total_tokens": 1604,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-15T22:55:11.923670"
}